Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke

Not yet recruiting

Phase 1 Results N/A

Summary of Purpose

The purpose of the study is to determine the safety and possible effectiveness of brain transplants of CD34+ stem cells obtained from umbilical cord blood (UCB) to treat stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 July 2012.

1 Jan 2013 7 Sep 2011 1 Dec 2013 1 Dec 2013 1 Dec 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts